Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Do medication adherence trajectories predict clinical endpoints in a cohort with HIV and chronic comorbidities?

Research in social & administrative pharmacy : RSAP·2026

Same author

Advancing Women-Centered Product Development: Understanding the Health Needs of Women Roundtable Proceedings.

Journal of women's health (2002)·2026

Same author

Impact of SARS-CoV-2 Breakthrough Infection on Short-Term CD4 Count Among Adults With HIV in the United States From 2020 to 2022.

Open forum infectious diseases·2026

Same author

Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.

The Journal of infectious diseases·2026

Same author

Long-acting injectable cabotegravir HIV PrEP uptake, adherence, and persistence in two large US integrated healthcare systems.

Journal of acquired immune deficiency syndromes (1999)·2026

Same author

New to Cohort, Not New to Care: Leveraging Historical Data in HIV Clinical Cohorts in the United States.

American journal of epidemiology·2026

Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026

Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026

Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026

Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026

Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026

Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

HIV testing, staging, and evaluation.

Carla V Rodriguez¹, Michael A Horberg²

¹Mid-Atlantic Permanente Research Institute, Kaiser Permanente, 2101 East Jefferson Street, 6 West, Rockville, MD 20852, USA.

Infectious Disease Clinics of North America

|August 25, 2014

Summary

This summary is machine-generated.

HIV testing and treatment have advanced, improving outcomes. However, primary prevention efforts must be enhanced, particularly for vulnerable populations, to curb ongoing transmission.

Keywords:

HIV epidemiology HIV surveillance

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

Related Experiment Videos

Last Updated: Apr 25, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

Area of Science:

Public Health
Infectious Diseases
Medical Science

Background:

HIV testing and incidence rates remain stable overall, but concerning trends exist within specific demographics.
Significant advancements in HIV diagnostics and therapeutics have been achieved, alongside policy changes aimed at improving access and affordability.
Current HIV care focuses on enhancing treatment adherence, achieving viral suppression, and managing long-term health outcomes and comorbidities.

Purpose of the Study:

To summarize the current state of HIV testing and treatment.
To highlight advancements in HIV diagnostics, therapeutics, and healthcare policy.
To identify persistent challenges in HIV prevention and long-term care.

Main Methods:

Review of current scientific literature on HIV testing and treatment.
Analysis of trends in HIV incidence and population-specific data.
Examination of policy changes impacting HIV diagnostics and care access.
Assessment of challenges in managing long-term HIV regimens and comorbidities.

Main Results:

HIV testing and incidence are stable, but concerning trends necessitate targeted interventions.
HIV diagnostics are more accurate, faster, private, and affordable.
Newer HIV treatments are more potent, better tolerated, and improve adherence and viral suppression.
Healthcare policy changes aim to expand access to diagnostics and treatment in the US.

Conclusions:

Reinvigorating primary prevention, especially for vulnerable groups, is crucial.
Continued efforts are needed to improve long-term outcomes and reduce comorbidities associated with lifelong HIV treatment.
Preventing further HIV transmission remains a key public health objective.